We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $22.8B
1-Year Est. Return 25.09%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+25.09%
3 Year Est. Return
+81.82%
5 Year Est. Return
+99.92%
10 Year Est. Return
+339.81%
AUM
$19.2B
AUM Growth
-$117M
Cap. Flow
-$328M
Cap. Flow %
-1.7%
Top 10 Hldgs %
45.98%
Holding
942
New
252
Increased
135
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$439M
2
PYPL icon
PayPal
PYPL
+$34.2M
3
SABR icon
Sabre
SABR
+$24.5M
4
BKU icon
Bankunited
BKU
+$16.1M
5
HEI.A icon
HEICO Corp Class A
HEI.A
+$10.9M

Top Sells

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$305M
2
PGR icon
Progressive
PGR
+$56.3M
3
CMCSA icon
Comcast
CMCSA
+$48.9M
4
USB icon
US Bancorp
USB
+$36.9M
5
MSFT icon
Microsoft
MSFT
+$31.7M

Sector Composition

Rank Sector Weight
1 Financials 24.69%
2 Technology 15.58%
3 Healthcare 12.75%
4 Communication Services 11.75%
5 Energy 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNSR
726
DELISTED
Finisar Corp
FNSR
$5K ﹤0.01%
+283
New +$4.84K
ACAD icon
727
Acadia Pharmaceuticals
ACAD
$5.07B
$4K ﹤0.01%
+110
New +$3.68K
ACHC icon
728
Acadia Healthcare
ACHC
$2.95B
$4K ﹤0.01%
+74
New +$4.33K
ACM icon
729
Aecom
ACM
$7.86B
$4K ﹤0.01%
+121
New +$3.83K
CBRL icon
730
Cracker Barrel
CBRL
$1.31B
$4K ﹤0.01%
+25
New +$3.9K
EEA
731
European Equity Fund
EEA
$77M
$4K ﹤0.01%
+500
New +$3.97K
EHC icon
732
Encompass Health
EHC
$12.3B
$4K ﹤0.01%
+145
New +$4.54K
ESGR
733
DELISTED
Enstar Group
ESGR
$4K ﹤0.01%
+22
New +$3.47K
GEN icon
734
Gen Digital
GEN
$17.1B
$4K ﹤0.01%
200
LXRX icon
735
Lexicon Pharmaceuticals
LXRX
$1.05B
$4K ﹤0.01%
+297
New +$4.03K
NBIX icon
736
Neurocrine Biosciences
NBIX
$15.9B
$4K ﹤0.01%
+92
New +$4.24K
OII icon
737
Oceaneering
OII
$5.08B
$4K ﹤0.01%
+148
New +$4.83K
PLD icon
738
Prologis
PLD
$134B
$4K ﹤0.01%
+81
New +$3.81K
POOL icon
739
Pool Corp
POOL
$7.25B
$4K ﹤0.01%
+42
New +$3.77K
PRA
740
DELISTED
ProAssurance
PRA
$4K ﹤0.01%
+74
New +$3.71K
QLYS icon
741
Qualys
QLYS
$6.47B
$4K ﹤0.01%
+133
New +$3.73K
SRG
742
Seritage Growth Properties
SRG
$131M
$4K ﹤0.01%
+76
New +$3.81K
TREX icon
743
Trex
TREX
$5.05B
$4K ﹤0.01%
+376
New +$4.24K
INVX
744
Innovex International
INVX
$2.13B
$4K ﹤0.01%
+62
New +$3.75K
PRAH
745
DELISTED
PRA Health Sciences, Inc.
PRAH
$4K ﹤0.01%
+87
New +$4.01K
DERM
746
DELISTED
Dermira, Inc.
DERM
$4K ﹤0.01%
+135
New +$3.73K
ELLI
747
DELISTED
Ellie Mae Inc
ELLI
$4K ﹤0.01%
+42
New +$3.57K
CSRA
748
DELISTED
CSRA Inc.
CSRA
$4K ﹤0.01%
+155
New +$3.9K
ABCO
749
DELISTED
Advisory Board Co
ABCO
$4K ﹤0.01%
+107
New +$3.52K
PRXL
750
DELISTED
Parexel International Corp
PRXL
$4K ﹤0.01%
+65
New +$4.02K

Similar funds

Brown Brothers Harriman & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Brown Brothers Harriman & Co held 942 positions worth $19.2B, down 0.61% from $19.4B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Brown Brothers Harriman & Co's Q2 2016 filing shows 252 new, 135 increased, 217 reduced and 105 closed positions. Its largest new stake was Sabre: 872,000 shares worth $23.4M. The largest sale was BAXALTA INC COM STK (DE), an estimated $305M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

  • Brown Brothers Harriman & Co's largest Q2 2016 buy was Sabre: 872,000 shares worth $23.4M.
  • Brown Brothers Harriman & Co added most to Perrigo in Q2 2016, an estimated $439M increase.
  • Brown Brothers Harriman & Co's biggest Q2 2016 reduction was Progressive, cutting an estimated $56.3M.
  • Brown Brothers Harriman & Co fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $305M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 46% of its $19.2B portfolio in Q2 2016.
  • Brown Brothers Harriman & Co opened 252 new positions and closed 105 in Q2 2016.
  • Brown Brothers Harriman & Co's portfolio value fell 0.61% quarter-over-quarter to $19.2B.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.